Shanghai Pharmaceuticals Holding Co's quarterly Total Liabilities
declined
from Sep. 2025 ($20,653.28 Mil) to Dec. 2025 ($20,354.59 Mil) but then
increased
from Dec. 2025 ($20,354.59 Mil) to Mar. 2026 ($20,879.26 Mil).
Shanghai Pharmaceuticals Holding Co's annual Total Liabilities
increased
from Dec. 2023 ($18,437.36 Mil) to Dec. 2024 ($18,881.02 Mil) and
increased
from Dec. 2024 ($18,881.02 Mil) to Dec. 2025 ($20,354.59 Mil).
Shanghai Pharmaceuticals Holding Co Total Liabilities Related Terms
Shanghai Pharmaceuticals Holding Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Pharmaceuticals Holding Co Total Liabilities Chart
Shanghai Pharmaceuticals Holding Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of $20,879 Mil mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Total Liabilities of $20,879 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Total Liabilities too high?
Shanghai Pharmaceuticals Holding Co's current Total Liabilities is $20,879 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Total Liabilities compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Total Liabilities of $20,879 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Total Liabilities is $20,879 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Total Liabilities of $20,879 Mil. The stock's GF Value™ is $1.89, compared to a current price of $1.46 — trading 22.8% below its estimated fair value. The current Total Liabilities is $20,879 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Total Liabilities is $20,879 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued.
The current stock price of $1.46 is trading 22.8% below its estimated GF Value™ of $1.89.
Key valuation signals for SHPMF:
Total Liabilities: $20,879 Mil
GF Value™: $1.89 vs. price of $1.46 (22.8% below fair value)
No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Pharmaceuticals Holding Co Business Description
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score
Get the complete analysis for SHPMF
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPMF has been successfully added to your 
